Alzheimer's drug study halted early: what we know
Disease control
Terminated
This study looked at the long-term safety and effects of a drug called XPro1595 in people with Alzheimer's disease who had already finished earlier studies. Only 11 people took part, and the study was stopped early. The main goal was to check for side effects and see if the drug …
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Apr 29, 2026 12:44 UTC